Corina N. D’alessandoro-Gabazza

Corina N. D’alessandoro-Gabazza

Auto-generated profile, based on publicly available information

Corina N. D’alessandoro-Gabazza

Department of Immunology, Faculty and Graduate School of Medicine, Mie University, Edobashi 2-174, Tsu 514-8507, Mie, Japan

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
TYTaro Yasuma
Taro Yasuma
MTMasaaki Toda
Masaaki Toda
AAAhmed Abdel-Hamid
Ahmed Abdel-Hamid
CDCorina D’alessandro-Gabazza
Corina D’alessandro-Gabazza
TKTetsu Kobayashi
Tetsu Kobayashi
Isaac CannIsaac Cann
Isaac Cann
Bacteroides spp. of the human colonic microbiome degrade complex arabinoxylans from dietary fiber and release ferulic acid. Several studies have demonstrated the beneficial effects of ferulic acid. Here, we hypothesized that ferulic acid or the ferulic acid-rich culture supernatant of Bacteroides intestinalis, cultured in the presence of complex arabinoxylans, enhances the immune response. Ferulic acid and the culture supernatant of bacteria cultured in the presence of insoluble arabinoxylans significantly decreased the expression of tumor necrosis factor-α and increased the expression of interleukin-10 and transforming growth factor β1 from activated dendritic cells compared to controls. The number of granulocytes in mesenteric lymph nodes, the number of spleen monocytes/granulocytes, and interleukin-2 and interleukin-12 plasma levels were significantly increased in mice treated with ferulic acid or the culture supernatant of bacteria cultured with insoluble arabinoxylans. Ferulic acid or the culture supernatant of bacteria cultured with insoluble arabinoxylans increased the expression of interleukin-12, interferon-α, and interferon-β in intestinal epithelial cell lines. This study shows that ferulic acid or the ferulic acid-rich culture supernatant of the colonic bacterium Bacteroides intestinalis, cultured with insoluble arabinoxylans, exerts anti-inflammatory activity in dendritic cells under inflammatory conditions and enhances the Th1-type immune response under physiological conditions in mice.

1 January 2012 in Respiratory Research
Verified
Journal Article
Open access
PDF file
TETomas M. Eagan
Tomas M. Eagan
Esteban C. GabazzaEsteban C. Gabazza
Esteban C. Gabazza
CDCorina D’alessandro-Gabazza
Corina D’alessandro-Gabazza
PGPaloma Gil-Bernabe
Paloma Gil-Bernabe
SAShinya Aoki
Shinya Aoki
PWPeter D Wagner
Peter D Wagner
Systemic inflammation may contribute to cachexia in patients with chronic obstructive pulmonary disease (COPD). In this longitudinal study we assessed the association between circulating C-reactive protein (CRP), tumor necrosis factor (TNF)-α, interleukin (IL)-1ß, and IL-6 levels and subsequent loss of fat free mass and fat mass in more than 400 COPD patients over three years.

15 December 2007 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
HFHajime Fujimoto
Hajime Fujimoto
CDCorina N. D'ALessandro-Gabazza
Corina N. D'ALessandro-Gabazza
MPMoorthy S. S. Palanki
Moorthy S. S. Palanki
PEPaul E. Erdman
Paul E. Erdman
TTTakehiro Takagi
Takehiro Takagi
OTOsamu Taguchi
Osamu Taguchi
Rationale: Cytokines secreted by T cells play a pivotal role in the pathogenesis of lung injury and fibrosis, and the transcription factors nuclear factor (NF)-κB and activator protein (AP)-1 are involved in the expression of cytokines from T cells during lung injury. Objectives: We assessed the potential therapeutic effect of SP100030, a specific inhibitor of T-cell NF-κB and AP-1 in lung fibrosis. Methods: The effect of SP100030 was evaluated using a mouse model of chronic lung fibrosis. Measurements and Main Results: Mice treated with SP100030, as compared with untreated mice, had significantly less cachexia and less lung injury and had decreased levels of inflammatory cytokines and growth factors, decreased activation of coagulation activation, and decreased collagen deposition in the lung. The inhibitory activity of SP100030 was dose dependent and was effective in acute and chronic phases of lung fibrosis. SP100030 inhibited the activation of the protein kinase Cθ-isoform in T-cell lines and suppressed NF-κB–driven cytokine expression in CD4+ and CD8+ T cells. Conclusions: These results suggest that the specific inhibition of NF-κB could be useful for the treatment of lung fibrosis.

14 April 2023 in Pathogens
Verified
Journal Article
Open access
PDF file
IIIchiro Imoto
Ichiro Imoto
TYTaro Yasuma
Taro Yasuma
CDCorina N. D’alessandro-Gabazza
Corina N. D’alessandro-Gabazza
SOSatoko Oka
Satoko Oka
MMMoriharu Misaki
Moriharu Misaki
Esteban C. GabazzaEsteban C. Gabazza
Esteban C. Gabazza
Helicobacter (H.) pylori is the primary causative agent of various gastroduodenal diseases. H. pylori is an adapted microorganism that has evolved to survive in the acidic conditions of the human stomach, possessing a natural strategy for colonizing harsh environments. Despite the implementation of various eradication regimens worldwide, the eradication rate of H. pylori has decreased to less than 80% in recent years due to the emergence of antibiotic-resistant strains. This has posed a significant challenge in treating H. pylori infection, as antibiotic resistance and side effects have become increasingly problematic. Lactoferrin, a member of the transferrin family, is an iron-binding protein with antioxidant, antibacterial, antiviral, and anti-inflammatory properties that promote human health. The concentrations of lactoferrin in the gastric juice and mucosa significantly increase during H. pylori infection and are strongly correlated with the severity of gastric mucosal inflammation. Numerous researchers have studied the antimicrobial properties of lactoferrin both in vitro and in vivo. In addition, recent studies have investigated the addition of oral lactoferrin supplementation to H. pylori eradication therapy, even though monotherapy with lactoferrin does not eradicate the microorganism. In this article, we reviewed the survival strategy of H. pylori to evade the antimicrobial activity of human lactoferrin and explore the potential of lactoferrin in H. pylori eradication therapy.

Verified
Journal Article
Open access
PDF file
RIRyo Inoue
Ryo Inoue
TYTaro Yasuma
Taro Yasuma
CDCorina D'Alessandro-Gabazza
Corina D'Alessandro-Gabazza
MTMasaaki Toda
Masaaki Toda
TIToshiyuki Ito
Toshiyuki Ito
Esteban C. GabazzaEsteban C. Gabazza
Esteban C. Gabazza
Idiopathic pulmonary fibrosis is a progressive and fatal disease with a poor prognosis. Matrix metalloproteinase-2 is involved in the pathogenesis of organ fibrosis. The role of matrix metalloproteinase-2 in lung fibrosis is unclear. This study evaluated whether overexpression of matrix metalloproteinase-2 affects the development of pulmonary fibrosis. Lung fibrosis was induced by bleomycin in wild-type mice and transgenic mice overexpressing human matrix metalloproteinase-2. Mice expressing human matrix metalloproteinase-2 showed significantly decreased infiltration of inflammatory cells and inflammatory and fibrotic cytokines in the lungs compared to wild-type mice after induction of lung injury and fibrosis with bleomycin. The computed tomography score, Ashcroft score of fibrosis, and lung collagen deposition were significantly reduced in human matrix metalloproteinase transgenic mice compared to wild-type mice. The expression of anti-apoptotic genes was significantly increased, while caspase-3 activity was significantly reduced in the lungs of matrix metalloproteinase-2 transgenic mice compared to wild-type mice. Active matrix metalloproteinase-2 significantly decreased bleomycin-induced apoptosis in alveolar epithelial cells. Matrix metalloproteinase-2 appears to protect against pulmonary fibrosis by inhibiting apoptosis of lung epithelial cells.

26 October 2021 in Cells
Verified
Journal Article
Open access
PDF file
HSHaruko Saiki
Haruko Saiki
YOYuko Okano
Yuko Okano
TYTaro Yasuma
Taro Yasuma
MTMasaaki Toda
Masaaki Toda
ATAtsuro Takeshita
Atsuro Takeshita
Esteban C. GabazzaEsteban C. Gabazza
Esteban C. Gabazza
Apoptosis is a programmed cell death involved in embryogenesis and tissue homeostasis under physiological conditions. However, abnormalities in the process of apoptosis are implicated in the pathogenesis of various diseases. The human microbiota may release products that induce apoptosis of host cells. We recently identified a novel microbiome-derived peptide called corisin that worsens lung fibrosis by inducing apoptosis of lung epithelial cells. We hypothesized that corisin and a corisin-like peptide might also induce apoptosis of cells from different tissues. We cultured podocytes, renal tubular epithelial cells, keratinocytes, retinal and intestinal cells treated with corisin and evaluated apoptosis by flow cytometry and Western blotting. Although at different grades, flow cytometry analysis and Western blotting showed that corisin and a corisin-like peptide induced apoptosis of podocytes, keratinocytes, tubular epithelial cells, retinal, and intestinal cells. In addition, we found that corisin synergistically enhances the proapoptotic activity of transforming growth factor-β1 on podocytes. In conclusion, these results suggest that corisin and corisin-like peptides may play a role in the pathogenesis of disease in different organs by promoting apoptosis of parenchymal cells.